Ozempic may help treat kidney disease in diabetic patients

Semaglutide, found in Ozempic and Wegovy, significantly reduced kidney complications, heart issues, and death in Type 2 diabetes patients with chronic kidney disease. The trial's success led Novo Nordisk to halt it early. The company plans to seek FDA approval to update Ozempic's label for treating chronic kidney disease in diabetic patients. Chronic kidney disease affects over one in seven US adults and has no cure.